Prostatic Neoplasms, drug therapy
- Name
- Prostatic Neoplasms, drug therapy
- Accession Number
- DBCAT002819
- Description
Not Available
- Drugs
Drug Drug Description Apalutamide An androgen receptor inhibitor used to treat non-metastatic castration-resistant and metastatic castration-sensitive prostate cancer. Relugolix An oral GnRH receptor antagonist for androgen deprivation therapy in the treatment of advanced prostate cancer. - Drugs & Drug Targets